Nutrition Beverage Tolerance Study

Updated 06/21/2024

Status Completed

Clinical Trial Summary

To evaluate the sensations experienced by subjects consuming a nutritional beverage.

Clinical Trial Description

n/a

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Crossover Assignment, Masking: Double Blind (Subject, Investigator, Outcomes Assessor), Primary Purpose: Treatment

Related Conditions & MeSH terms

Human Volunteers

Clinical Trial Details

NCT number	NCT01464385
Study type	Interventional
Source	Abbott Nutrition
Contact
Status	Completed
Phase	Phase 2
Start date	October 2011
Completion date	December 2011

See also
	Status	Clinical Trial	Phase
	Completed	`NCT03093506` - Effects of Micro-dose and Low-dose Recombinant Human Erythropoietin on Mitochondrial Function and Cognitive Performance	Early Phase 1
	Completed	`NCT00526968` - The Effects of a Novel NMDA NR2B-Subtype Selective Antagonist, EVT 101, on Brain Function	Phase 1
	Completed	`NCT03277456` - A Study to Determine the Safety and Immunogenicity of the Candidate Influenza Vaccine MVA-NP+M1	Early Phase 1
	Completed	`NCT02922933` - A Study to Examine the Effect of Omeprazole, Famotidine, and an Acidic Beverage on the Pharmacokinetics of Entinostat in Healthy Adult Subjects	Phase 1
	Completed	`NCT01452425` - In Vivo Optical Spectroscopy Monitoring in a New Model of Muscular Compartment Syndrome	Phase 1
	Completed	`NCT01468714` - A Study To Estimate The Effect Of Ketoconazole On The Pharmacokinetics Of Pf-04937319 In Healthy Subjects	Phase 1
	Completed	`NCT02922946` - Study to Determine the Effect of the Timing of a Meal on the Pharmacokinetics of Entinostat	Phase 1
	Completed	`NCT00254449` - Effect of NGX-4010 on ENFD and Sensory Function	Phase 1
	Completed	`NCT01618877` - A Randomized, Double-blind, Pharmacokinetics Study to Assess Safety, Tolerability of Levetiracetam 45 Minutes Intravenous Infusion During 4 Days of Bid Dosing in Chinese Healthy Volunteers	Phase 1
	Completed	`NCT01618903` - An Open-label, Bioequivalence Study to Evaluate LEV Administered as a 45-min Intravenous Infusion and Same Dosage LEV Oral Tablet in Chinese	Phase 1
	Completed	`NCT00752466` - A Drug Interaction Study of the Pharmacokinetics of Topiramate and FLUNARIZINE When Given Together or Separately	Phase 1
	Completed	`NCT00166933` - Minimal Erythema Dose of UV-B in Normal Population of Taiwan	N/A
	Completed	`NCT05519514` - Bio-Equivalence Study of Budesonide Prolonged-release Tablets 9 Mg In Healthy Human Adult Subjects	Phase 1
	Completed	`NCT01776437` - Study of BMN 673, a PARP Inhibitor, in Healthy Adult Male Volunteers	Phase 1
	Completed	`NCT01437033` - Breath Test for Chemicals (Volatile Organic Compounds)
	Completed	`NCT01445860` - Drug-Drug Interaction Study Of Effect Of PF-03882845 On Simvastatin Pharmacokinetics	Phase 1
	Completed	`NCT00744809` - TMC278-TiDP6-C152: A Study to Assess the Effects of TMC278 and Efavirenz (EFV) on the QT/QTc Interval (Heart Conduction and Heart Rhythm) in Healthy Volunteers.	Phase 1
	Unknown status	`NCT00743977` - Bioequivalence of Phenazopyridine HCl in Healthy Volunteers	N/A